Physician profile
Sally Dee
NPI 1427140177
$1,532.19
in general payments reported to CMS, 2019-2025
16 companies · $187 in 2025
The $187 reported for 2025 was less than what a typical Allergy & Immunology provider received nationally (typical 2025 total: $1,138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $280 · 2020: $27.24 · 2021: $159 · 2022: $242 · 2023: $493 · 2024: $143 · 2025: $187.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $678 · Education: $145.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $677.80 |
| Education | $145.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $430.86 | 2019-2025 | Xolair |
| Astrazeneca Pharmaceuticals LP | $303.04 | 2019-2025 | Tezspire, Airsupra, Fasenra |
| Regeneron Healthcare Solutions, INC. | $283.56 | 2022-2023 | Dupixent |
| Takeda Pharmaceuticals U.S.A., INC. | $206.52 | 2021-2023 | Cuvitru |
| Optinose US, INC. | $48.17 | 2019-2025 | |
| Pharming Healthcare, INC. | $32.67 | 2023 | Ruconest |
| Shire North American Group INC | $30.91 | 2019 | |
| Novartis Pharmaceuticals Corporation | $30.01 | 2025 | |
| Kaleo, INC. | $27.81 | 2019 | |
| Aimmune Therapeutics, INC. | $27.24 | 2020 | |
| Ars Pharmaceuticals Operations, INC. | $26.01 | 2025 | Neffy |
| Merck Sharp & Dohme LLC | $20.41 | 2023 | |
| Alk-Abello, INC | $17.75 | 2025 | Neffy, Odactra, Ragwitek |
| Glaxosmithkline, LLC. | $16.41 | 2019 | |
| Genzyme Corporation | $15.92 | 2025 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.90 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sally Dee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.